Generally, there are two interventions requiring to prevent cervical cancer – cervical screening with treatment of early abnormalities, and the Human Papillomavirus (HPV) vaccine. With high coverage of women in the population, these two interventions together can prevent almost 100% of cervical cancers. The HPV vaccine protects against 2 strains of the HPV virus, which cause 70% of cervical cancers. In the long-term, cervical screening and treatment of early lesions will still need to be a core component of cervical cancer prevention, as 30% of cervical cancers will not be prevented by the vaccine. Cervical cancer most commonly affects women in their 40s, so once the HPV vaccine is implemented in Cambodia, reductions in cervical cancer incidence
